Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PROK ProKidney Corp
- Stocks
- Healthcare
- NASDAQ: PROK
Price (delayed)
$0.8066
Market cap
$236.09M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.6
Enterprise value
$141.66M
Highlights
ProKidney's equity has increased by 9% YoY
ProKidney's debt has decreased by 43% YoY but it has increased by 4.1% from the previous quarter
The EPS has declined by 5% year-on-year but it has increased by 3.2% since the previous quarter
The net income has dropped by 94% year-on-year and by 12% since the previous quarter
PROK's quick ratio is down by 41% YoY
Key stats
What are the main financial stats of PROK
Market
Valuations
Earnings
Shares outstanding
292.7M
Market cap
$236.09M
Enterprise value
$141.66M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
339.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
462.94
Revenue
$306,000
Gross profit
$306,000
Operating income
-$184.99M
Net income
-$68.43M
EBIT
-$68.53M
EBITDA
-$62.6M
Free cash flow
-$150.98M
Per share
Balance sheet
Liquidity
EPS
-$0.6
EPS diluted
-$0.6
Free cash flow per share
-$1.17
Book value per share
-$3.41
Revenue per share
$0
TBVPS
$3.15
Total assets
$406.06M
Total liabilities
$36.08M
Debt
$3.37M
Equity
-$998.55M
Working capital
$326.85M
Debt to equity
0
Current ratio
10.96
Quick ratio
10.01
Net debt/EBITDA
1.51
Margins
Efficiency
Dividend
EBITDA margin
-20,456.2%
Gross margin
100%
Net margin
-22,362.1%
Operating margin
-60,453.6%
Return on assets
-15%
Return on equity
N/A
Return on invested capital
-22.7%
Return on capital employed
-18.4%
Return on sales
-22,394.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PROK stock price
How has the ProKidney stock price performed over time
Intraday
-5.07%
1 week
11.81%
1 month
1.34%
1 year
-78.72%
YTD
-52.27%
QTD
-7.94%
Financial performance
How have ProKidney's revenue and profit performed over time
Revenue
$306,000
Gross profit
$306,000
Operating income
-$184.99M
Net income
-$68.43M
Gross margin
100%
Net margin
-22,362.1%
The net income has dropped by 94% year-on-year and by 12% since the previous quarter
ProKidney's operating margin has surged by 75% QoQ
ProKidney's net margin has soared by 72% from the previous quarter
ProKidney's operating income has decreased by 23% YoY
Price vs fundamentals
How does PROK's price correlate with its fundamentals
Growth
What is ProKidney's growth rate over time
Valuation
What is ProKidney stock price valuation
P/E
N/A
P/B
N/A
P/S
339.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
462.94
The EPS has declined by 5% year-on-year but it has increased by 3.2% since the previous quarter
ProKidney's equity has increased by 9% YoY
Efficiency
How efficient is ProKidney business performance
The return on invested capital has dropped by 103% year-on-year and by 12% since the previous quarter
The return on assets has dropped by 85% year-on-year and by 10% since the previous quarter
The return on sales has surged by 72% since the previous quarter
Dividends
What is PROK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PROK.
Financial health
How did ProKidney financials performed over time
ProKidney's total liabilities has increased by 46% YoY but it has decreased by 8% QoQ
PROK's quick ratio is down by 41% YoY
ProKidney's debt is 100% more than its equity
The debt to equity has soared by 100% year-on-year
ProKidney's debt has decreased by 43% YoY but it has increased by 4.1% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.